C World Wide Group Holding A Ultragenyx Pharmaceutical Inc. Transaction History

C World Wide Group Holding A

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$54.93 - $74.36 $2.1 Million - $2.84 Million	-38,168 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$39.87 - $69.36 $653,987 - $1.14 Million	16,403 Added 75.36%	38,168 $2.65 Million
Q4 2018 Feb 12, 2019	SELL	$38.89 - $77.3 $878,330 - $1.75 Million	-22,585 Reduced 50.92%	21,765 $946,000
Q3 2018 Nov 05, 2018	SELL	$71.81 - $90.15 $609,236 - $764,832	-8,484 Reduced 16.06%	44,350 $3.39 Million
Q2 2018 Aug 03, 2018	SELL	$48.54 - $85.31 $443,801 - $779,989	-9,143 Reduced 14.75%	52,834 $4.06 Million
Q1 2018 May 03, 2018	SELL	$44.33 - $58.52 $419,494 - $553,774	-9,463 Reduced 13.25%	61,977 $3.16 Million
Q4 2017 Feb 07, 2018	SELL	$43.54 - $57.32 $272,168 - $358,307	-6,251 Reduced 8.05%	71,440 $3.31 Million
Q3 2017 Nov 06, 2017	BUY	$49.79 - $66.32 $3.87 Million - $5.15 Million	77,691	77,691 $4.14 Million

325

85.6M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.09B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.